Terry P Gould - Net Worth and Insider Trading
Terry P Gould Net Worth
The estimated net worth of Terry P Gould is at least $10 Million dollars as of 2024-06-10. Terry P Gould is the Director, 10% Owner of Corvus Pharmaceuticals Inc and owns about 2,814,187 shares of Corvus Pharmaceuticals Inc (CRVS) stock worth over $6 Million. Terry P Gould is the Director of Icosavax Inc and owns about 256,783 shares of Icosavax Inc (ICVX) stock worth over $4 Million. Terry P Gould is also the Director, 10% Owner of Aptinyx Inc and owns about 695,326 shares of Aptinyx Inc (APTX) stock worth over $66,751. Details can be seen in Terry P Gould's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Terry P Gould has not made any transactions after 2021-08-02 and currently still holds the listed stock(s).
Transaction Summary of Terry P Gould
Terry P Gould Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Terry P Gould owns 4 companies in total, including Aptinyx Inc (APTX) , Corvus Pharmaceuticals Inc (CRVS) , and OncoMed Pharmaceuticals Inc (OMED) among others .
Click here to see the complete history of Terry P Gould’s form 4 insider trades.
Insider Ownership Summary of Terry P Gould
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| APTX | Aptinyx Inc | 2018-06-25 | director & 10 percent owner |
| CRVS | Corvus Pharmaceuticals Inc | 2018-03-12 | director & 10 percent owner |
| OMED | OncoMed Pharmaceuticals Inc | 2016-06-22 | director |
 | | 2021-08-02 | director & 10 percent owner |
Terry P Gould Latest Holdings Summary
Terry P Gould currently owns a total of 3 stocks. Among these stocks, Terry P Gould owns 2,814,187 shares of Corvus Pharmaceuticals Inc (CRVS) as of March 12, 2018, with a value of $6 Million and a weighting of 58.83%. Terry P Gould owns 256,783 shares of Icosavax Inc (ICVX) as of August 2, 2021, with a value of $4 Million and a weighting of 40.48%. Terry P Gould also owns 695,326 shares of Aptinyx Inc (APTX) as of June 25, 2018, with a value of $66,751 and a weighting of 0.69%.
Latest Holdings of Terry P Gould
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRVS | Corvus Pharmaceuticals Inc | 2018-03-12 | 2,814,187 | 2.03 | 5,712,800 |
| ICVX | Icosavax Inc | 2021-08-02 | 256,783 | 15.31 | 3,931,348 |
| APTX | Aptinyx Inc | 2018-06-25 | 695,326 | 0.10 | 66,751 |
Holding Weightings of Terry P Gould
Terry P Gould Form 4 Trading Tracker
According to the SEC Form 4 filings, Terry P Gould has made a total of 0 transactions in Corvus Pharmaceuticals Inc (CRVS) over the past 5 years. The most-recent trade in Corvus Pharmaceuticals Inc is the acquisition of 588,235 shares on March 12, 2018, which cost Terry P Gould around $5 Million.
According to the SEC Form 4 filings, Terry P Gould has made a total of 1 transactions in Icosavax Inc (ICVX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Icosavax Inc is the acquisition of 133,334 shares on August 2, 2021, which cost Terry P Gould around $2 Million.
According to the SEC Form 4 filings, Terry P Gould has made a total of 0 transactions in Aptinyx Inc (APTX) over the past 5 years. The most-recent trade in Aptinyx Inc is the acquisition of 150,000 shares on June 25, 2018, which cost Terry P Gould around $2 Million.
Insider Trading History of Terry P Gould
- 1
Terry P Gould Trading Performance
GuruFocus tracks the stock performance after each of Terry P Gould's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Terry P Gould is 27.39%. GuruFocus also compares Terry P Gould's trading performance to market benchmark return within the same time period. The performance of stocks bought by Terry P Gould within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Terry P Gould's insider trading performs compared to the benchmark.
Performance of Terry P Gould
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.82 | | | | | |
| Relative Return to S&P 500(%) | 13.72 | | | | | |
Terry P Gould Ownership Network
Terry P Gould Owned Company Details
What does Aptinyx Inc do?
Who are the key executives at Aptinyx Inc?
Terry P Gould is the director & 10 percent owner of Aptinyx Inc. Other key executives at Aptinyx Inc include director & CEO and President Norbert G Riedel , CFO and CBO Ashish Khanna , and 10 percent owner Bain Capital Life Sciences Investors, Llc .
Aptinyx Inc (APTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aptinyx Inc (APTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aptinyx Inc (APTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aptinyx Inc (APTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aptinyx Inc Insider Transactions
Terry P Gould Mailing Address
Above is the net worth, insider trading, and ownership report for Terry P Gould. You might contact Terry P Gould via mailing address: C/o Oncomed Pharmaceuticals, Inc., 800 Chesapeake Drive, Redwood City Ca 94063.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
